Diphenylhydantoin Effects on Human Lymphocytes in Vitro and in Vivo
- 1 June 1972
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 129 (6) , 988-992
- https://doi.org/10.1001/archinte.1972.00320060136020
Abstract
We investigated the problem of idiosyncratic reactions to diphenylhydantoin sodium (Dilantin) using tissue culture techniques and measurement of absolute peripheral lymphocyte numbers and immunoglobulin serum values. Diphenylhydantoin was used as antigen to stimulate peripheral blood lymphocyte cultures of 8 patients with serious reactions to the drug, 23 patients without reactions, and 8 normal controls. Diphenylhydantoin inhibited thymidine incorporation in cultures of patients with serious reactions to diphenylhydantoin. Patients who were taking diphenylhydantoin without reaction had lower proportions of DNA synthesizing cells in seven-day unstimulated cultures than normal controls. Sixty-six patients receiving the drug were shown to have negative correlation between serum diphenylhydantoin level and the absolute peripheral blood lymphocyte numbers. Immunoglobulin quantitation of matched groups of 20 patients showed decrease in IgG levels in serum of those receiving diphenylhydantoin. An hypothesis relating these data to the development of lymphoma and autoimmune phenomena is offered.This publication has 6 references indexed in Scilit:
- Malignant Lymphoma Associated With Hydantoin DrugsArchives of Neurology, 1970
- Further Observations on Spontaneous Blastoid Transformation of Human Small Lymphocytes in VitroBritish Journal of Haematology, 1969
- Folic Acid Deficiency from Anticonvulsant TherapyDevelopmental Medicine and Child Neurology, 1968
- Immunologic deficiency, autoimmune disease, and lymphoma: Observations, implications, and speculationsArthritis & Rheumatism, 1966
- Diphenylhydantoin-induced hypersensitivity reactionThe Journal of Pediatrics, 1965
- The Effect of Phytohemagglutinin on Leukocyte Cultures as Measured by P32 Incorporation in the DNA, RNA, and Acid Soluble FractionsBlood, 1962